Optimized transcriptional signature for evaluation of MEK/ERK pathway baseline activity and long-term modulations in ovarian cancer
M. S. Chesnokov, A. Yadav, I. Chefetz
The paper validates a multi-cancer transcriptional signature for MEK/ERK pathway activity in ovarian cancer using experimental models and TCGA data, showing gene expression associations with survival and treatment resistance.
bioRxiv · Mar 21, 2022Cancer Biology